PL356119A1 - Preparat farmaceutyczny zawierający inhibitor karboksypeptydazy U i inhibitor trombiny - Google Patents

Preparat farmaceutyczny zawierający inhibitor karboksypeptydazy U i inhibitor trombiny

Info

Publication number
PL356119A1
PL356119A1 PL00356119A PL35611900A PL356119A1 PL 356119 A1 PL356119 A1 PL 356119A1 PL 00356119 A PL00356119 A PL 00356119A PL 35611900 A PL35611900 A PL 35611900A PL 356119 A1 PL356119 A1 PL 356119A1
Authority
PL
Poland
Prior art keywords
inhibitor
carboxypeptidase
pharmaceutical formulation
formulation containing
thrombin
Prior art date
Application number
PL00356119A
Other languages
English (en)
Other versions
PL203505B1 (pl
Inventor
Tommy Abrahamsson
Viveca Nerme
Magnus Polla
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9901573A external-priority patent/SE9901573D0/xx
Priority claimed from SE9901572A external-priority patent/SE9901572D0/xx
Priority claimed from SE9902902A external-priority patent/SE9902902D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL356119A1 publication Critical patent/PL356119A1/pl
Publication of PL203505B1 publication Critical patent/PL203505B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL356119A 1999-05-03 2000-05-03 Preparat farmaceutyczny zawieraj acy inhibitor karboksypeptydazy U i inhibitor trombiny, zestaw sk ladników i zastosowanie preparatu farmaceutycznego PL203505B1 (pl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE9901573-7 1999-05-03
SE9901572-9 1999-05-03
SE9901573A SE9901573D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds
SE9902902A SE9902902D0 (sv) 1999-08-13 1999-08-13 New formulation
SE9902902-7 1999-08-13
PCT/SE2000/000847 WO2000066152A1 (en) 1999-05-03 2000-05-03 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor

Publications (2)

Publication Number Publication Date
PL356119A1 true PL356119A1 (pl) 2004-06-14
PL203505B1 PL203505B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
HK1042442A1 (en) 2002-08-16
JP2002543148A (ja) 2002-12-17
EP1181048A1 (en) 2002-02-27
WO2000066152A1 (en) 2000-11-09
AU763772B2 (en) 2003-07-31
KR20020003386A (ko) 2002-01-12
IL145951A0 (en) 2002-07-25
AU4447200A (en) 2000-11-17
NZ515063A (en) 2003-08-29
BR0010255A (pt) 2002-02-13
ATE447964T1 (de) 2009-11-15
US6974800B1 (en) 2005-12-13
MY126962A (en) 2006-11-30
ES2335383T3 (es) 2010-03-26
TR200103151T2 (tr) 2002-04-22
CN1350463A (zh) 2002-05-22
DE60043297D1 (de) 2009-12-24
AR023819A1 (es) 2002-09-04
EP1181048B1 (en) 2009-11-11
KR100725206B1 (ko) 2007-06-07
CZ20013932A3 (cs) 2002-04-17
CN100518820C (zh) 2009-07-29
HK1042442B (en) 2010-04-09
HUP0201615A2 (en) 2002-09-28
IS6140A (is) 2001-11-01
EE200100578A (et) 2003-02-17
TWI232106B (en) 2005-05-11
SK15652001A3 (sk) 2002-07-02
NO20015308D0 (no) 2001-10-30
MXPA01011044A (es) 2002-06-04
HUP0201615A3 (en) 2006-07-28
NO20015308L (no) 2001-12-03
CA2371217A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
HUP0000657A3 (en) N-arylsulfonyl-piperidine, -morpholine hydroxamic acid derivatives and pharmaceutical compositions containing them
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
EG24044A (en) pharmaceutical formulation of omeprazole
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
HUP9900964A3 (en) Protease inhibitors and pharmaceutical compositions containing these compounds
HUP0101613A3 (en) Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same
IL133613A0 (en) Epothilone derivatives and pharmaceutical compositions containing same
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
HUP0001319A3 (en) Heteroaryl carboxylic amide derivatives and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
HUP0100186A3 (en) Compounds as lactam metalloprotease inhibitors and pharmaceutical compositions containing them
HUP0201680A3 (en) Aromatic sulfone hydroxamic acid derivatives metalloprotease inhibitors and pharmaceutical compositions containing them
IL119466A0 (en) Thrombin inhibitors their preparation and pharmaceutical compositions containing them
HUP0002510A3 (en) Tetrazole derivatives and pharmaceutical compositions containing them
ZA988017B (en) Parp inhibitors pharmaceutical compositions comprising same and methods of using same
HUP0002951A3 (en) Bis-aminomethylcarbonyl compounds as protease inhibitors and pharmaceutical compositions containing them
PL348026A1 (en) Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
IL145954A0 (en) A new inhibitor of carboxypeptidase u
HUP9902256A3 (en) Amidino protease inhibitors and pharmaceutical compositions containing them
PL351917A1 (en) Pharmaceutical preparation containing low molecular mass thrombin inhibitor and its agonist
HUP0201615A2 (en) A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
IL117247A0 (en) Pharmaceutical compositions comprising protease inhibitors and quinoxalines
IL145953A0 (en) A new inhibitor of carboxypeptidase u